Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Study of Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection

NCT01018381 is registered in ClinicalTrials.gov with The 108 Military Central Hospital as lead sponsor.

NCT NCT01018381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01018381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Study of Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection
Lead sponsor
The 108 Military Central Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2006
Completion date
November 30, 2009
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, hepatocellular carcinoma